Profile data is unavailable for this security.
About the company
Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
- Revenue in ILS (TTM)2.48m
- Net income in ILS-27.36m
- Incorporated1994
- Employees5.00
- LocationCan-Fite Biopharma Ltd26 Ben Gurion StreetRAMAT GAN 5257346IsraelISR
- Phone+972 39241114
- Fax+972 39249378
- Websitehttps://www.canfite.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cilo Cybin Holdings Ltd | -21.11bn | -21.11bn | 58.47m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 182.51 | -- | -- | -- |
Corline Biomedical AB | 6.20m | -2.28m | 58.50m | 14.00 | -- | 1.89 | -- | 9.43 | -0.3005 | -0.3005 | 0.8165 | 4.07 | 0.1729 | -- | 4.69 | 1,349,769.00 | -6.36 | -5.71 | -7.13 | -6.24 | 141.25 | 128.60 | -36.80 | -38.46 | -- | -306.52 | 0.00 | -- | 6.28 | 74.14 | -177.67 | -- | 62.51 | -- |
Lasa Supergenerics Ltd | 46.28m | -8.63m | 60.02m | 77.00 | -- | -- | -- | 1.30 | -3.92 | -3.92 | 20.94 | -- | -- | -- | -- | 13,586,300.00 | -- | -3.86 | -- | -5.34 | 26.41 | 32.53 | -18.65 | -5.30 | -- | -4.49 | -- | -- | -19.47 | -9.26 | 43.73 | -- | -- | -- |
Marinomed Biotech AG | 26.68m | -27.75m | 61.50m | 47.00 | -- | -- | -- | 2.30 | -4.46 | -4.46 | 4.28 | -7.69 | -- | -- | -- | 140,468.10 | -- | -33.46 | -- | -48.73 | 10.56 | 7.67 | -103.99 | -69.70 | 1.46 | -4.51 | 2.20 | -- | -18.56 | 14.50 | -6.21 | -- | -10.92 | -- |
Cosma SA | 3.71m | -44.15m | 61.51m | 31.00 | -- | 1.92 | -- | 16.58 | -0.4301 | -0.4301 | 0.0362 | 0.2343 | 0.0733 | 0.8409 | 3.05 | 136,278.60 | -87.24 | -- | -91.46 | -- | 58.45 | -- | -1,189.90 | -- | 0.5634 | -129.62 | 0.0119 | -- | -- | -- | -18,399.08 | -- | -- | -- |
Vaidya Sane Ayurved Laboratories Ltd | 43.94m | 876.08k | 62.33m | 636.00 | 80.54 | 2.53 | 27.45 | 1.42 | 1.66 | 1.66 | 78.54 | 52.89 | 1.58 | 6.83 | 15.11 | 1,561,813.00 | 3.16 | 4.83 | 4.02 | 7.49 | 74.12 | 70.91 | 2.00 | 2.53 | 2.11 | 5.49 | 0.0293 | -- | 0.1638 | 9.71 | -59.02 | 31.91 | 4.43 | -- |
Can Fite Biopharma Ltd | 2.48m | -27.36m | 62.70m | 5.00 | -- | 5.57 | -- | 25.33 | -0.0175 | -0.0175 | 0.0016 | 0.0055 | 0.0787 | -- | -- | 495,100.80 | -86.95 | -102.29 | -115.77 | -131.07 | -- | -- | -1,105.10 | -1,105.36 | -- | -- | 0.00 | -- | -8.27 | -27.92 | 24.96 | -- | -42.92 | -- |
Devonian Health Group Inc | 26.28m | -8.54m | 63.91m | 6.00 | -- | 1.78 | -- | 2.43 | -0.0216 | -0.0216 | 0.0665 | 0.09 | 0.4423 | 33.07 | 2.32 | 1,625,238.00 | -14.37 | -21.02 | -23.15 | -23.96 | 30.95 | 29.96 | -32.50 | -131.97 | 1.06 | -9.41 | 0.1406 | -- | 1.74 | -5.83 | -33.39 | -- | -- | -- |
Cumberland Pharmaceuticals, Inc. | 140.53m | -38.59m | 65.53m | 91.00 | -- | 0.6681 | -- | 0.4663 | -0.7328 | -0.7328 | 2.67 | 1.87 | 0.4501 | 0.8643 | 3.17 | 415,225.80 | -12.35 | -7.03 | -17.75 | -9.52 | 82.58 | 79.95 | -27.45 | -17.64 | 1.26 | -38.85 | 0.382 | -- | -5.85 | 6.15 | -12.73 | -- | -36.17 | -- |
Enorama Pharma AB | 2.07m | -14.64m | 66.89m | 5.00 | -- | 6.40 | -- | 32.24 | -0.9211 | -0.9211 | 0.1295 | 0.6408 | 0.1413 | 1.20 | 2.94 | 1,173,800.00 | -99.66 | -73.56 | -147.35 | -104.85 | -32.71 | 43.36 | -705.54 | -557.42 | 2.00 | -29.36 | 0.0094 | -- | -80.17 | -23.71 | -6.15 | -- | -- | -- |
Sotac Pharmaceuticals Ltd | 48.74m | 1.65m | 67.07m | 89.00 | 40.75 | -- | 21.34 | 1.38 | 3.37 | 3.37 | 99.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.53 | -- | 3.38 | -- | -- | 2.75 | -- | -- | 79.07 | -- | -20.38 | -- | -- | -- |
IX Biopharma Ltd | 16.91m | -30.64m | 67.70m | 56.00 | -- | 4.78 | -- | 4.00 | -0.014 | -0.014 | 0.0078 | 0.0057 | 0.3013 | 4.20 | 1.99 | -- | -54.58 | -39.79 | -86.37 | -52.71 | 17.59 | 50.67 | -181.14 | -150.87 | 0.7053 | -2.42 | 0.5451 | -- | 0.778 | 54.77 | -12.26 | -- | -29.94 | -- |
Data as of Oct 15 2024. Currency figures normalised to Can-Fite Biopharma Ltd's reporting currency: Israeli Shekel ILS